SciBase Strengthens the US Organization With Experienced Leader in Dermatology
SciBase Strengthens the US Organization With Experienced Leader in Dermatology
"We see Leda's experience as instrumental for driving growth and making SciBase successful in the U.S. as we build on the base we have now created for further expansion", says STOCKHOLM, June 13, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), SciBase, a leading developer of AI-based solutions for skin diseases, today announces that Leda Beaty has been appointed Head of US Commercial Operations.
2024年6月13日，斯德哥爾摩 / PRNewswire——皮膚科技公司SciBase Holding AB（以下簡稱“SciBase”）（斯德哥爾摩證券交易所：SCIB）SciBase，一家領先的面向皮膚病的基於人工智能的解決方案開發商，今天宣佈任命Leda Beaty爲美國商業運營主管。
SciBase is pleased to announce that Leda will be heading the US commercial operations. With an extensive background in sales and commercialization across pharmaceutical, medical devices and biotechnology she brings over 27 years of experience to this pivotal role. Leda joins from DermTech Inc., a skin cancer detection company, where she was Senior National Director, responsible for creating partnerships with leading clinicians, building strategic partnerships and market expansion in dermatology.
SciBase 很高興地宣佈，Leda 將負責美國商業運營主管工作。她在藥品、醫療設備和生物技術領域擁有27年以上的銷售和商業化經驗，對於這個關鍵的角色她有着豐富的經驗。Leda來自皮膚癌檢測公司DermTech Inc，擔任高級國家主管，負責與領先臨床醫生建立夥伴關係、構建戰略伙伴關係以及推動皮膚病市場的擴張。
Her expertise spans startup environments and the successful launches of products at renowned companies including Aventis, Amgen, Arthrex and DermTech. Leda has concentrated her efforts in the field of dermatology. Her experience in launching and driving sales of new products and technologies, building winning teams in the US dermatology market as well as experience in cost reimbursement in the US, will be key to driving SciBase US sales and market establishment forward.
她的專業知識涵蓋啓動環境和在知名公司（包括Aventis、Amgen、Arthrex和DermTech）成功推出產品。Leda專注於皮膚病領域。她在推出和推動新產品和技術的銷售、在美國皮膚科市場建立獲勝團隊以及在美國成本報銷方面的經驗，將是推動 SciBase 美國銷售和市場建立的關鍵。
"We see Leda's experience as instrumental for driving growth and making SciBase successful in the U.S. as we build on the base we have now created for further expansion", says Pia Renaudin, CEO of SciBase.
“我們認爲Leda的經驗對於推動SciBase在美國的增長和成功至關重要，因爲我們要在我們已經爲進一步擴張創造的基礎上繼續努力，”SciBase 的首席執行官Pia Renaudin說。
For additional information, please contact:
Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected]
欲了解更多信息，請聯繫:
Pia Renaudin，VD，電話+46 732069802，電子郵件：[email protected]
Certified Advisor (CA):
認證顧問（CA）：
Vator Securities
Tel: +46 8 580 065 99
Email: [email protected]
Vator Securities
電話：+46858006599
電子郵件：[email protected]
About SciBase:
關於SciBase：
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
SciBase是一家全球性醫療技術公司，專注於皮膚疾病的早期檢測和預防。SciBase開發和商業化Nevisense，這是一種獨特的點對點平台，結合了人工智能和先進的電阻抗譜技術，提高了診斷準確性，確保積極的皮膚健康管理。
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
我們致力於減少患者的痛苦，使臨床醫生通過及時檢測和干預來改善和挽救生命，並降低醫療保健成本。
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
SciBase在瑞典斯德哥爾摩的卡羅林斯卡學院進行了20多年的研究，是皮膚病學進展的領先者。
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at . All press releases and financial reports can be found here:
該公司自2015年6月2日在納斯達克創業板上市。請訪問了解更多信息。所有新聞發佈和財務報告都可以在此找到：
This information was brought to you by Cision
本信息由Cision提供
The following files are available for download:
以下文件可供下載：
|
PM_Leda US eng_final |
|
PM_Leda美國工程_final |
SOURCE SciBase
來源：SciBase
